Global Health

Global Health EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Global Health (MEDANTA.NS) as of Nov 8, 2026 is 11.80 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 15.46 % — a change of -23.69% (lower).

EBIT/Assets

11.80 %

YoY

-23.69%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Global Health is 2026 11.80 % . Operating Income to Assets Ratio (EBIT/Assets) of Global Health was 2025 15.46 % . It decreases by -23.69% lower compared to the previous year.

The Global Health EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2019
2.93 INR
Jan 1, 2020
3.64 INR
Jan 1, 2021
3.44 INR
Jan 1, 2022
10.33 INR
Jan 1, 2023
12.13 INR
Jan 1, 2024
15.29 INR
Jan 1, 2025
15.46 INR
Jan 1, 2026
11.80 INR
The Global Health EBIT/Assets history
YEAREBIT/AssetsYoY
11.80 %-23.69%
15.46 %+1.07%
15.29 %+26.13%
12.13 %+17.40%
10.33 %+200.16%
3.44 %-5.38%
3.64 %+24.22%
2.93 %-64.97%
8.36 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Global Health Stock analysis

What does Global Health do? Global Health Ltd. provides healthcare, pathology, and medical services through its Medanta brand, operating five hospitals in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow, alongside six Mediclinic diagnostic laboratories. The company generates revenue by delivering treatments for conditions such as coronary artery disease, head and neck cancer, acute myeloid leukemia, and chronic kidney disease, alongside specialized services in cardiac surgery, nephrology, urology, and interventional cardiology. Its offerings include medicine delivery, lab tests & diagnostics, homecare, and telemedicine, targeting patients seeking advanced medical care across multiple specialties. Medanta serves urban and semi-urban segments in India, focusing on high-demand treatments and comprehensive healthcare solutions. The company monetizes through direct patient services at its hospitals and diagnostic centers, with revenue derived from procedures, consultations, and diagnostic tests. Treatments for chronic conditions like diabetes, hypertension, and bronchial asthma, as well as acute cases such as cerebral stroke and sepsis, form a significant portion of its service portfolio. Patients utilize Medanta’s telemedicine and homecare services for convenience, while its diagnostic labs provide lab tests & diagnostics to both in-person and remote clients. Revenue streams are driven by high-volume treatments and specialized medical expertise across its network of facilities. Medanta’s service mix includes cardiology, oncology, neurology, and orthopedics, with a focus on conditions like Parkinson’s disease, prostate cancer, and rheumatoid arthritis. The company’s revenue model relies on comprehensive care packages, including hospital stays, outpatient visits, and follow-up services. Its facilities in Delhi, Gurugram, and other cities cater to both private and government-affiliated patients, though the business description does not specify government contracts. The company’s diagnostic laboratories and telemedicine services expand its reach, enabling revenue from multiple touchpoints within the healthcare ecosystem. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

Operating Income to Assets Ratio (EBIT/Assets) of Global Health is 11.80 % in 2026.

Operating Income to Assets Ratio (EBIT/Assets) of Global Health changed from 15.46 % to 11.80 %, representing a -23.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Global Health since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Global Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Global Health

All Key Metrics — Global Health